Dr. John Hogenesch

Dr. John Hogenesch received his PhD in Neuroscience in the laboratory of Christopher Bradfield at Northwestern University and, while there, characterized several members of the bHLH-PAS family of transcription factors, including the partner of Clock, Mop3/Bmal. He went on to do his postdoctoral training with Dr. Steve Kay at the Scripps Research Institute working on developing methods to describe the circadian transcriptome in Arabidopsis and Drosophila, as well as approaches to begin to construct systems level descriptions of circadian gene regulation. Subsequently, Dr. Hogenesch became a Staff Scientist and later Head of Genomics at the Genomics Institute of the Novartis Research Foundation. Currently, Dr. Hogenesch is in the Department of Pharmacology at the University of Pennsylvania (http://www.med.upenn.edu/pharm) where his lab conducts research on the mechanisms of circadian rhythms in mammals. His current research interests include light regulation of the clock, transcriptional output of the clock, and core clock mechanism. He is also an Associate Director of the Penn Genomics Institute where he runs a core for Cell Based Screening. More information...